Randomized trial · people

Tesamorelin cut visceral and liver fat over 6 months in HIV patients

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In people with HIV, 6 months of tesamorelin lowered belly fat and modestly lowered liver fat, with an early rise in fasting glucose that was no longer significant at 6 months.

Kind
Randomized trial
Studied in
People
Number studied
50
Published
2014
Journal
JAMA

What they tested

The team wanted to know whether daily tesamorelin lowers both visceral fat (fat inside the belly) and liver fat in people with HIV who carry extra abdominal fat.

How the study was done

A double-blind, randomized, placebo-controlled trial at one Boston hospital in 50 men and women with HIV on antiretroviral treatment and abdominal fat buildup. They got tesamorelin 2 mg (28 people) or placebo, a dummy shot (22 people), as a daily injection under the skin for 6 months.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking tesamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Visceral fat fell by an average of 34 cm2 on tesamorelin and rose by 8 cm2 on placebo, a significant treatment effect of -42 cm2. Liver fat, measured as a lipid to water percentage, dropped by a median of 2.0% on tesamorelin and rose by 0.9% on placebo, a significant net effect of -2.9%. Fasting glucose went up more on tesamorelin at 2 weeks (9 mg/dL vs 2 mg/dL), a significant difference. By 6 months, the differences in fasting glucose and 2-hour glucose between groups were not significant.

What it doesn’t show

This was a small, preliminary trial at a single center that lasted 6 months, and it only included people with HIV and extra abdominal fat. It does not show whether the fat changes matter for health or what happens over the long term.

The paper

Stanley et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. JAMA. 2014.

The compound

More studies on Tesamorelin

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking tesamorelin? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo